183 related articles for article (PubMed ID: 162030)
1. [Examination of lymphokines in patients with hemodialysis (author's transl)].
Löcsey L; Kálmán K; Hauck M; Kakuk G
Allerg Immunol (Leipz); 1979; 25(3):211-7. PubMed ID: 162030
[TBL] [Abstract][Full Text] [Related]
2. MLC-blocking factors in uremic sera.
Fehrman I; Ringdén O; Bergström J
Clin Nephrol; 1980 Oct; 14(4):183-9. PubMed ID: 7000408
[TBL] [Abstract][Full Text] [Related]
3. The effect of uraemic "middle-sized molecules" on T lymphocyte functions.
Kálmán K; Löcsey L; Hauck M; Leövey A
Int Urol Nephrol; 1980; 12(4):367-74. PubMed ID: 6763010
[TBL] [Abstract][Full Text] [Related]
4. Production of leukocyte migration inhibition factor (LIF) and migration stimulation factor (MStF) by CD4+ and CD8+ human lymphocytes subsets and T-cell clones.
Méndez-Samperio P; Jiménez-Zamudio L; Favila-Castillo L
Rev Invest Clin; 1989; 41(2):107-15. PubMed ID: 2675234
[TBL] [Abstract][Full Text] [Related]
5. Evidence of suppressor activity mediated by concanavalin-A stimulated cells towards aspecific LIF production.
Beatrice F; Poggio E; Morra B; Cavallo GP; Di Fortunato V; Bussi M; Vercellino M; Sartoris A; Cortesina G
G Batteriol Virol Immunol; 1982; 75(1-6):16-24. PubMed ID: 6227515
[TBL] [Abstract][Full Text] [Related]
6. Influence of uremic middle molecules on in vitro stimulated lymphocytes and interleukin-2 production.
Severini G; Diana L; Di Giovannandrea R; Sagliaschi G
ASAIO J; 1996; 42(1):64-7. PubMed ID: 8808461
[TBL] [Abstract][Full Text] [Related]
7. "In vitro" and "in vivo" leukocyte migration inhibitory factor production in acute infectious mononucleosis patients.
Bertotto A; Gentili F; Stagni G; Zucchetti Z; Vaccaro R
Boll Ist Sieroter Milan; 1983 Jul; 62(3):281-6. PubMed ID: 6357231
[TBL] [Abstract][Full Text] [Related]
8. Human lymphocytes produce both leukocyte migration inhibition (LIF) and stimulation (MStF) factors after mitogen, alloantigens or antigen activation.
Favila-Castillo L; Méndez-Samperio P; Cortés-Castillo MA; Sánchez-Ortega A
Rev Latinoam Microbiol; 1988; 30(2):111-5. PubMed ID: 3064229
[No Abstract] [Full Text] [Related]
9. Effect of histamine on leukocyte migration tests in vertebrates. II. Study of the lack of species specificity of leukocyte inhibiting factor--production inhibitor (LIF-PI).
Rigal D; Monier JC; Mohanna K
Thymus; 1983; 5(1):53-7. PubMed ID: 6342215
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.
Ringoir SM; van Landschoot N; de Smet R
Clin Nephrol; 1980 Mar; 13(3):109-12. PubMed ID: 7379359
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of interferon on the production on virus- and mitogen-induced leukocyte inhibitory factors in human leukocyte cultures.
Dinh PN; Rosztóczy I; Béládi I; Tóth M
Acta Virol; 1980 Dec; 24(6):427-32. PubMed ID: 6163345
[TBL] [Abstract][Full Text] [Related]
12. Middle molecular weight substances and uremic polyneuropathy.
Dukanović L; Petrović J; Potić J
Acta Med Iugosl; 1990; 44(2):117-28. PubMed ID: 2162129
[TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
14. [A comparison of the efficiency of eliminating middle-weight molecules and myoinositol from plasma during hemoperfusion and hemodialysis in cases of chronic uremia].
Trznadel K; Kidawa Z; Walasek L; Lutz W
Pol Tyg Lek; 1978 Feb; 33(7):257-9. PubMed ID: 758030
[No Abstract] [Full Text] [Related]
15. [Production of the leukocyte inhibitory factor (LIF) by peripheral blood lymphocytes in vitro and LIF-like plasma activity in paraproteinemic patients].
Puppo F; Corsini G; Mangini P; Armani U; Piana A
Haematologica; 1984; 69(4):394-402. PubMed ID: 6437916
[No Abstract] [Full Text] [Related]
16. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
Popławski A; Myśliwiec M; Soszka J
Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):810-3. PubMed ID: 2096374
[TBL] [Abstract][Full Text] [Related]
17. Effect of the cryopreservation on the production of leukocyte migration inhibition factor (LIF) by lymphocytes from normal volunteers and patients with laryngeal carcinomas.
Cavallo GP; Beatrice F; Poggio E; Bussi M; Di Fortunato V; Rendine S; Sartoris A; Cortesina G
Boll Ist Sieroter Milan; 1980 May; 59(2):147-54. PubMed ID: 7006629
[TBL] [Abstract][Full Text] [Related]
18. In vitro production of leucocyte migration inhibitory factor by lymphocytes in exudative pleural effusions.
Pettersson T; Welin MG; Weber TH
J Clin Lab Immunol; 1982 Jun; 8(2):107-11. PubMed ID: 7050387
[TBL] [Abstract][Full Text] [Related]
19. Production of migration inhibition factor (MIF) by purified human T cell subpopulations.
Warrington RJ; Olivier SL; Sauder PJ; Rutherford WJ
Clin Exp Immunol; 1981 May; 44(2):324-31. PubMed ID: 6458429
[TBL] [Abstract][Full Text] [Related]
20. Action of middle molecules from chronic renal insufficiency treated by hemodialysis on mitochondrial respiration.
Rinaudo JB; Gallice P; Crevat A; Saingra S; Murisasco A
Biomedicine; 1979 Oct; 30(4):215-8. PubMed ID: 534675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
